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Introduction: Septic shock is a medical emergency that, despite the
medical advances that have been made, still remains a major cause of
hospital deaths. Cell therapy is an innovative field of research that could
provide a therapy for sepsis. Mesenchymal stromal cells (MSC) are
promising in cell therapy and more importantly for sepsis because of
their immunosuppressive capabilities [1]. MSC have been shown by
several groups to have a positive effect against sepsis in vivo [2-4]. It has
been predicted that the MSC interact with macrophage to release IL-10
that in turns reduces inflammation [4]. Other groups have focused on the
use of stimulated MSC to ameliorate their immunosuppressive capabilities
[5]. The main stimulation of MSC has been the use of inflammatory
stimulants like IFNg. Our work focuses on the identification of effective
MSC donors, whether primed with IFNg or naïve, and the development of
in vitro models that will predict how an MSC donor will act in vivo. We
also want to eliminate the use of cells completely and use their secreted
microvesicles as a therapy. The hypothesis is that the in vitro models will
eliminate a noneffective MSC donor and allow us to identify the MSC
donor that will have the greatest effect.
Methods: We developed two in vitro models that are similar to what
happens in vivo with WBC as they circulate in a septic patient. The first test
is the adherence of WBC to a layer of HUVECs in the presence of MSC or
microvesicles. The second is a permeability test to determine MSC ability
to block the permeability of a HUVEC layer.
Results: Our preliminary results have shown that we are able to identify,
using our two in vitro models, which MSC donor would be an effective
MSC for cell therapy.
Conclusion: MSC and their paracrine factors have to the potential to be
an effective therapy for sepsis, but one needs to identify an effective
donor before use in cell therapy.
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Introduction: The Endotoxin Activity Assay (EAA™; Spectral Diagnostics Inc.,
Toronto, Canada) is a useful diagnostic test for sepsis due to Gram-negative
infection and is based on the reaction of neutrophils to endotoxin
complexed with an anti-endotoxin antibody. However, the relations
between values of EAA and microbiological data have not been elucidated.
Our hypothesis is that EAA values correlate to the results of microbiological
cultures and also severity.
Methods: From July 2008 to July 2013, all adult patients with suspected
sepsis admitted to our medico-surgical ICU in whom EAA was measured
were included in this study. Data collected included age, gender, ICU
mortality, white blood cell (WBC) count, C-reactive protein (CRP),
procalcitonin (PCT), EAA levels, SOFA score and results of microbiological
culture. Patients with no microbiological data were excluded. Data were
analyzed by Kruskal-Wallis test, Mann-Whitney U test and multivariate
logistic regression. P < 0.05 was considered significant.
Results: Of 569 patients (353 men and 216 women; mean age 66.0 ±
17.4 years), 283 patients had Gram-negative infection and 286 patients
had no Gram-negative infection. Of 283 patients with Gram-negative
infection, 65 patients had Gram-negative organisms in blood. EAA levels
were significantly different between patients with Gram-negative blood,
in other infectious sites and no Gram-negative infection (0.45 ± 0.21 vs.
0.39 ± 0.17 vs. 0.36 ± 0.15, P = 0.03). The odds ratio (95% confidence
interval (CI)) of EAA levels for Gram-negative infection and Gram-negative
bacteremia were 3.89 (1.44 to 10.4) (P = 0.007) and 3.36 (2.16 to 40.6)
(P = 0.003), respectively. The odds ratio and CI of age and SOFA score for
ICU mortality were 1.03 (1.01 to 1.04) (P = 0.0003) and 1.33 (1.26 to 1.41)
(P < 0.0001), respectively, while gender, WBC, CRP, PCT and EAA levels
had no relations with ICU mortality. SOFA score was significantly higher
in patients with Gram-negative infection than in patients with no Gram-
negative infection (8.0 ± 4.6 vs. 6.7 ± 4.2, P = 0.0003).
Conclusion: EAA levels related to the detections of Gram-negative
organisms in cultures. Thus, a high EAA level may show the existence of
Gram-negative organisms in patients’ sites. EAA levels had relations with
SOFA score but no relations with ICU mortality.
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Introduction: The Endotoxin Activity Assay (EAA™; Spectral Diagnostics Inc.,
Toronto, Canada) is a rapid in vitro diagnostic test of the neutrophil reaction
to endotoxin and reflects the endotoxemia. A higher value of EAA (>0.60)
has been shown to correlate with developing severe sepsis and a high
mortality in other previous studies. We hypothesize that a value of EAA
more than 0.55, not >0.60, may be useful to earlier diagnose sepsis due to
Gram-negative organisms and to assess the severity.
Methods: The present study is a single-center retrospective observational
analysis of adult septic patients in whom EAA was performed from July 2008
to July 2013. Patients were divided into two groups: (1) EAA >0.55 and (2)
EAA < 0.54. Age, sex, days of ICU stay, ICU mortality, body temperature,
WBC, CRP, procalcitonin (PCT), SOFA score, and microbiological data were
compared between two groups. Values are expressed as mean ± SD. Data
were analyzed by chi-square test and Mann-Whitney U test. P < 0.05 was
considered significant. The sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV) and odds ratio were also evaluated.
Results: Five hundred and ninety-four patients (377 men and 217 women;
mean age 65.0 ± 17.5 years) were studied. There were (1) 104 patients with
EAA >0.55 and (2) 490 patients with EAA < 0.54. ICU mortality (39.4 vs. 26.6
%, P = 0.01), PCT (17.2 ± 36.0 vs. 11.8 ± vs. 30.6 ng/ml, P = 0.04), SOFA score
(8.1 ± 4.9 vs. 6.2 ± 4.6, P = 0.04) and positive Gram-negative organisms in
cultures (57.7 vs. 45.5 %, P = 0.02) were significantly higher in group (1) than
group (2). Age, sex, body temperature, WBC and CRP were not significantly
different between two groups. Using detections of Gram-negative
organisms in cultures, the sensitivity, the specificity, the PPV and the NPV
were 22.1, 85.2, 57.7 and 54.6%, respectively. The odds ratio was 1.64.
Conclusion: ICU mortality and severity were higher in patients with EAA
>0.55 than in patients with EAA < 0.54. There is a possibility that an EAA
Critical Care 2014, Volume 18 Suppl 2
http://ccforum.com/supplements/18/S2
Page 51 of 53
value more than 0.55 is a meaningful value for early diagnosis of sepsis
due to Gram-negative infection.
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Introduction: Dengue fever is one of the most important seasonal
epidemics in Asia Case fatality rates vary from 1 to 5% [1]. Mortality from
severe dengue may range from 26% in DHF to as high as 47% in DSS [2,3].
The pathogenesis of shock in dengue fever (DF) is centered on increased
capillary permeability in the critical phase leading to hypovolemia and shock
in severe dengue. There have been multiple studies that compare fluid
regimens in the management of dengue [4,5]. These studies do not assess
the child’s renal function and ability to handle the fluid loads. GFR <60 ml/
minute indicates a significant decrease in the renal functioning and there
are no pediatric studies that examine their association with in-hospital stay
and outcomes in children with severe dengue. With this introduction we
formulated this study protocol to examine that association. The objectives
were to measure the estimated glomerular filtration rate (eGFR) at admission
and fluid balance in the first 36 hours of ICU stay and assess their effect on
disease course and outcomes in severe dengue.
Methods: This was designed as a retrospective descriptive study in a
tertiary-level pediatric ICU in South India. Case records of all children
fulfilling the WHO case definition of severe dengue were included, those
who received intravenous fluid for less than 12 hours were excluded.
Primary parameters measured included fluid balance in the first 36 hours
measured every 12 hours, durations of oxygen requirement, mechanical
ventilation, ICU stay and total hospital stay. Outcomes measured were death
and survival.
Results: Twenty-six children were enrolled, 14 boys and 12 girls. The
median duration of ICU stay was 60 hours, and that of hospital stay 109
hours. eGFR was less than 60 ml/minute in six patients (83.3% expired and
16.7% survived). eGFR, measured by modified Schwartz’s formula, at the
time of admission correlated inversely with requirement of oxygen therapy
and mechanical ventilation (P < 0.05) and fluid balance in the first 36 hours.
Positive fluid balance (FO > 15%) in the first 36 hours was significantly
higher in children who expired (P = 0.011). eGFR <90 ml/minute at
admission had 100% sensitivity and 79% specificity to predict the possible
occurrence of fluid overload >15% (area under curve = 0.882).
Conclusion: Fluid balance in the first 36 hours had a significant positive
correlation with mortality and negative correlation with eGFR. Children with
admission eGFR <90 ml/minute may require restrictive fluid therapy to
improve survival.
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Introduction: This audit evaluates the adherence to the prophylactic
surgical antibiotic policy at Kingston Hospital. With a greater understanding
of the current use of prophylactic surgical antibiotics comes the ability to
improve patient care while minimising the development of antibiotic
resistance. Surgical site infections are a major source of hospital-acquired
infections, causing significant morbidity and mortality. In appropriate cases,
surgical antibiotic prophylaxis is essential in preventing such infections;
however, this comes with increased risks of antibiotic resistance and
antibiotic-associated diarrhoea. Consequently, this institution has extensive
guidelines as to the cases in which antibiotic prophylaxis is required and
what antibiotics should be administered. This audit examines the adherence
to these guidelines. We audited against our local antibiotic prescribing
policy, named the Blue Book guidelines.
Methods: Notes were audited retrospectively for 80 patients undergoing
surgery between 19 August and 18 December 2013. These were audited
against local antibiotic guidelines (Blue Book guidelines) and analysed using
descriptive statistics.
Results: Only 57% of operations were compliant with Blue Book antibiotic
prophylaxis guidelines. For operations where administration of antibiotics
was appropriate, 24% of patients received the incorrect choice, 19% were
given the incorrect dose, 28% were given antibiotics for an inappropriate
time relative to the procedure, and 38% received antibiotics for the incorrect
duration. For operations not requiring prophylaxis, 48% of patients
incorrectly received antibiotics.
Conclusion: Compliance to local guidelines for prophylactic antibiotics is
extremely poor. This not only risks increased morbidity and mortality
from surgical site infections but also risks the development of antibiotic
resistance and Clostridium difficile colitis.
We suggest enhancement of the antibiotic guidelines, and education of
those using them. This will improve the provision of antibiotic prophylaxis in
the Trust, and ultimately improve patient care.
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Introduction: Delay in diagnosis and initiation of antibiotic treatment has
been shown to increase mortality. Biomarkers can play an important role in
diagnosis and prognosis of sepsis. We aimed to evaluate the correlation
between septicemia and high-density lipoprotein (HDL) level in burned
patients.
Methods: A prospective study conducted at Al-Sadr teaching hospital,
Maysan, Iraq, during the period from April to September 2013. Blood
samples were collected from patients every other day to measure the level
of HDL and triglycerides. Other blood samples were collected in blood
culture tubes for culturing to verify septicemia depending on the clinical
evidence.
Table 1(abstract P77) Characteristics of patients
Patient characteristic Average Range
Age (years) 17 1 to 85
TBSA% 33.5% 15 to 95%
Sex of patients Female 61% Male 39%
Burn type Scalds 48% Flame 52%
Most patients were female (61%) with average age 17 years and a wide range
of burned surface area (15 to 95%)
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